candesartan cilexetil has been researched along with Aging in 7 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan cilexetil treatment improved cardiac structural remodeling and cardiac function in SDT rats." | 5.35 | Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis. ( Fukumoto, M; Hayashi, T; Ikeda, T; Jin, D; Kitaura, Y; Miyazaki, M; Oku, H; Sugiyama, T; Takai, S, 2009) |
| " To examine the role of the renin-angiotensin system in hypertension in the elderly, we evaluated the antihypertensive response to enalapril and to TCV-116, an angiotensin II type-1 receptor antagonist, in elderly patients with essential hypertension." | 5.07 | Role of the renin-angiotensin system in hypertension in the elderly. ( Higaki, J; Mikami, H; Nagano, M; Ogihara, T, 1994) |
| "Candesartan cilexetil treatment improved cardiac structural remodeling and cardiac function in SDT rats." | 1.35 | Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis. ( Fukumoto, M; Hayashi, T; Ikeda, T; Jin, D; Kitaura, Y; Miyazaki, M; Oku, H; Sugiyama, T; Takai, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, D | 1 |
| Takai, S | 1 |
| Sugiyama, T | 1 |
| Hayashi, T | 1 |
| Fukumoto, M | 1 |
| Oku, H | 1 |
| Kitaura, Y | 1 |
| Ikeda, T | 1 |
| Miyazaki, M | 1 |
| Saupe, KW | 1 |
| Sobol, SC | 1 |
| Koh, SG | 1 |
| Apstein, CS | 1 |
| Jones, ES | 1 |
| Black, MJ | 1 |
| Widdop, RE | 1 |
| Ishiguro, K | 1 |
| Sasamura, H | 1 |
| Sakamaki, Y | 1 |
| Itoh, H | 1 |
| Saruta, T | 1 |
| Nagano, M | 1 |
| Higaki, J | 1 |
| Mikami, H | 1 |
| Ogihara, T | 1 |
| Hansson, L | 1 |
| Lithell, H | 1 |
| Skoog, I | 1 |
| Baro, F | 1 |
| Bánki, CM | 1 |
| Breteler, M | 1 |
| Castaigne, A | 1 |
| Correia, M | 1 |
| Degaute, JP | 1 |
| Elmfeldt, D | 1 |
| Engedal, K | 1 |
| Farsang, C | 1 |
| Ferro, J | 1 |
| Hachinski, V | 1 |
| Hofman, A | 1 |
| James, OF | 1 |
| Krisin, E | 1 |
| Leeman, M | 1 |
| de Leeuw, PW | 1 |
| Leys, D | 1 |
| Lobo, A | 1 |
| Nordby, G | 1 |
| Olofsson, B | 1 |
| Opolski, G | 1 |
| Prince, M | 1 |
| Reischies, FM | 1 |
| Kansui, Y | 1 |
| Fujii, K | 1 |
| Goto, K | 1 |
| Abe, I | 1 |
| Iida, M | 1 |
2 trials available for candesartan cilexetil and Aging
| Article | Year |
|---|---|
Role of the renin-angiotensin system in hypertension in the elderly.
Topics: Adult; Aged; Aging; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzi | 1994 |
Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.
Topics: Aged; Aged, 80 and over; Aging; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimida | 2000 |
5 other studies available for candesartan cilexetil and Aging
| Article | Year |
|---|---|
Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; An | 2009 |
Effects of AT1 receptor block begun late in life on normal cardiac aging in rats.
Topics: Adenosine; Aging; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compoun | 2003 |
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Block | 2004 |
Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Topics: Aging; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles | 2007 |
Angiotensin II receptor antagonist improves age-related endothelial dysfunction.
Topics: Acetylcholine; Aging; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; An | 2002 |